Ontario Institute for Cancer Research

Join us on October 31 for an in-person talk by Dr. Andrew Zhang on "Chemical Biology Tools for Target Deconvolution: Probes, Constructs, and Assays for Target Engagement and Mechanistic Understanding". RSVP: https://lnkd.in/gscJWDug

In our latest Ask a Cancer Researcher video, Dr. Saman Maleki talks about the gut microbiome in relation to cancer. Watch to learn why a microbiome transplant might be important for patients undergoing immunotherapy. #immunotherapy #guthealth #microbiome Lawson Health Research Institute Western University

❗️New funding opportunity: OICR invites applications for Innovation to Implementation (I2I) awards Through the I2I funding competition, OICR seeks to bridge the gaps between research products and their use in real-world settings by facilitating behaviour or system changes. We are currently inviting applications for projects that are in-scope, including:  ✅ Projects aimed at facilitating the adoption of research output, interventions, policies, or practices in the healthcare system using scientific methods and drawing on implementation science. ✅ Projects focused on developing and testing implementation science methods or strategies to facilitate uptake and integration of research outputs, interventions, policies, or practices in the healthcare system.  ✅ Projects investigating the barriers to implementation or developing optimal solutions to implementation challenges in the context of the Ontario healthcare system. ✅ Projects evaluating the comparative effectiveness and cost effectiveness of different implementation strategies in the oncology ecosystem. Deadlines:  Open for applications (via ReportNet): The week of October 7, 2024 Letter of Intent (LOI) deadline: December 5, 2024 by 5 p.m. ET LOI results communicated: Week of February 17, 2025 Full application deadline: April 10, 2025 by 5 p.m. ET Notification of results: June 2025 Funding start date: July 1, 2025 For more details and to view the RFA, please visit: https://lnkd.in/gnWmfJSd

Our recently-published Impact Report showcases the broad-ranging impacts made by OICR-affiliated scientists, clinicians and patient partners over the past year – what they mean for now and what they mean for the future. It shows how our collective efforts, as Ontario’s cancer research institute, are delivering on our commitment to improve the lives of people today, as well as future generations. https://lnkd.in/eVD3QP4

CanPath is teaming up with the Canadian Urban Environmental Health Research Consortium (CANUE) to bring you 17 new environmental exposure datasets! 🌿🌍 Discover datasets that include measures of green spaces and vegetation (e.g., NDVI, Landsat, MODIS), air quality (PM2.5, smoke exposure), accessibility and transportation, and socioeconomic conditions. Our expert presenters will showcase practical examples of how these datasets can revolutionize research on chronic diseases, cancer, and environmental health. Learn about powerful tools to explore the spatial dimensions of health determinants. This webinar is a must-attend for researchers, epidemiologists, data scientists, and public health professionals alike who are eager to expand their toolkit and leverage nationally harmonized cohort data to uncover the impact of environmental exposures on health. Presenters: ⭐ Dr. Trevor Dummer, National Scientific Co-Director of CanPath ⭐ Sheraz Cheema, MSc (MHI), Data Manager at CanPath ⭐ Dany Doiron, Managing Director of CANUE ⭐ Joseph Syer, CANUE Data Director Register now and join us for an inspiring webinar! #HealthResearch #EnvironmentalHealth #DataScience #PublicHealth #Epidemiology #CanPath15 #15YearsAndCounting

Oral cancers are typically imaged at the time of diagnosis, about month or two before a patient has surgery. Researchers with OICR’s Imaging Program have developed an ultrasound scanner that in just 15 minutes can provide accurate, up-to-date information about the size and shape of the tumour just prior to surgery, which can help improve surgical outcomes. https://lnkd.in/eR5xgHM2 #oralcancer #ultrasound #imaging

Phase 2 of Ontario’s Life Sciences Strategy is another major step forward for #research and #lifesciences in this province. We applaud the plan’s investments in clinical trials infrastructure and wet lab space, as well as the new Health Innovation Pathway to streamline the adoption of new technologies into the healthcare system. These efforts will be critical to launching made-in-Ontario biotech companies and bringing #cancer innovations to Ontarians who need them. ONeconomy | ÉconomieON Victor Fedeli Colleges and Universities | Collèges et Universités Nolan Quinn David O'Neill

OICR congratulates Dr. Bishal Gyawali on being named as a Fellow of the American Society of Clinical Oncology! This honour recognizes exceptional contributions to the field of oncology and dedication to advancing cancer care. We are proud to support Dr. Gyawali's work.

Congratulations to Dr. Faiyaz Notta and the team at the Princess Margaret Cancer Centre for winning the 2023 Co-operative and Experiential Education (CEE) Employer Impact Award for Impact in Research from the University of Waterloo! This award is in recognition of their work training UW co-op students while carrying out cutting edge #pancreaticcancer research. https://lnkd.in/eCq-Nh7w

Congratulations to legendary University of Toronto computer scientist Dr. Geoffrey Hinton on winning the 2024 Nobel Prize in Physics. The huge advancements in machine learning and neural networks that have improved — and will continue to improve — how we detect, diagnose and treat #cancer are due in large part to Dr. Hinton’s visionary work. https://lnkd.in/gbkyWD84